Northwest Biotherapeutics (NWBO) Treasury Shares (2012 - 2026)
Northwest Biotherapeutics' (NWBO) quarterly Treasury Shares came in at $12000.0 in Q1 2026, little changed quarter-over-quarter from $12000.0 in Q4 2025.
Northwest Biotherapeutics (NWBO) Treasury Shares (2012 - 2026) Analysis & Trends
Northwest Biotherapeutics' Treasury Shares history runs 8 years deep, the most recent figure standing at $12.0 million for Q1 2026.
- On a quarterly basis, Treasury Shares changed N/A year-over-year to $12000.0 in Q1 2026; TTM through Mar 2026 was $12000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $12000.0, changed N/A from the prior year.
- Treasury Shares held at $12000.0 in Q1 2026 per NWBO's latest filing, from $12000.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $12.0 million in Q4 2025 and bottomed at $818000.0 in Q3 2025.
- The 4-year median for Treasury Shares is $904000.0 (2025), against an average of $4.1 million.
- Across the five-year window, Treasury Shares jumped 1133.3% in 2025 and surged 1227.43% in 2026, its largest moves.
- Year by year, Treasury Shares stood at $12000.0 in 2025, then changed by 0.0% to $12000.0 in 2026.
- Per Business Quant, the three latest NWBO Treasury Shares figures stand at $12.0 million (Q1 2026), $12.0 million (Q4 2025), and $818000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,930.72 Bn | 1,930.66 Bn | - | 265,401.92 |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 471.36 Bn | 466.57 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 123.47 Bn | 116.22 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.52 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.00 Bn | 62.00 Bn | - | - |
| 8 | Argenx Se | 56.08 Bn | 50.89 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | - |
| 10 | Northwest Biotherapeutics | 272.43 Mn | 270.65 Mn | - | 12.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,000.00 |
| Mar 31, 2026 | 12,000.00 |
| Mar 31, 2026 | 12.00 Mn |
| Mar 31, 2026 | 12.00 Mn |
| Dec 31, 2025 | 12.00 Mn |
| Dec 31, 2025 | 12.00 Mn |
| Dec 31, 2025 | 12,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | 818,000.00 |
| Sep 30, 2025 | 818,000.00 |
| Jun 30, 2025 | 842,000.00 |
| Jun 30, 2025 | 842,000.00 |
| Mar 31, 2025 | 904,000.00 |
| Mar 31, 2025 | 904,000.00 |
| Dec 31, 2024 | 973,000.00 |
| Dec 31, 2024 | 973,000.00 |
| Sep 30, 2022 | 885,000.00 |
| Sep 30, 2022 | 885,000.00 |
| Jun 30, 2018 | 3,219.00 |
| Jun 30, 2018 | 3,219.00 |